Literature DB >> 10029148

Histological and compositional evaluations of three types of calcium phosphate cements when implanted in subcutaneous tissue immediately after mixing.

Y Miyamoto1, K Ishikawa, M Takechi, T Toh, T Yuasa, M Nagayama, K Suzuki.   

Abstract

To evaluate the soft tissue response of calcium phosphate cement (CPC), consisting of an equimolar mixture of tetracalcium phosphate (TTCP) and dicalcium phosphate anhydrous (DCPA) under conditions close to those encountered in actual surgical procedures, we implanted three types of CPC [conventional CPC (c-CPC), fast-setting CPC (FSCPC), and antiwashout type FSCPC (aw-FSCPC; formerly called nondecay type FSCPC or nd-FSCPC)] subcutaneously in the abdomens of rats immediately (1 min) after mixing. At 1 week after surgery, histological examination and compositional analysis were performed using light microscopy and powder X-ray diffraction (XRD), respectively. The implanted c-CPC was crumbled completely, whereas FSCPC and aw-FSCPC retained their shape. Large vesicles containing copious inflammatory effusion were subcutaneously formed around the c-CPC. Histologically, many foreign-body giant cells were collected around the c-CPC, and moderate inflammatory cell infiltration was observed at 1 week after surgery. In contrast, the FSCPC and aw-FSCPC were covered with a thin layer of granulation tissue that included few giant cells and presented slight inflammatory cell infiltration, and no effusion was observed. The XRD analysis of the c-CPC revealed the presence of some unreacted DCPA even 1 week after implantation, whereas almost no DCPA was found in the FSCPC or aw-FSCPC. In conclusion, it was found that CPC does not always show excellent tissue response. When c-CPC is implanted subcutaneously in rats immediately after mixing, it fails to set and causes a severe inflammatory response. Therefore, the type of CPC should be chosen according to the clinical particulars. CPC should be used in a manner that assures its setting reaction. We recommend the use of FSCPC and aw-FSCPC for surgical applications, such as orthopedics, plastic and reconstructive surgery, and oral and maxillofacial surgery, where the cement might otherwise crumble due to the pressure before setting.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029148     DOI: 10.1002/(sici)1097-4636(1999)48:1<36::aid-jbm8>3.0.co;2-i

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  32 in total

1.  Tissue responses to anti-washout apatite cement using chitosan when implanted in the rat tibia.

Authors:  M Takechi; K Ishikawa; Y Miyamoto; M Nagayama; K Suzuki
Journal:  J Mater Sci Mater Med       Date:  2001-07       Impact factor: 3.896

2.  Synthesis, material properties, and biocompatibility of a novel self-cross-linkable poly(caprolactone fumarate) as an injectable tissue engineering scaffold.

Authors:  Esmaiel Jabbari; Shanfeng Wang; Lichun Lu; James A Gruetzmacher; Syed Ameenuddin; Theresa E Hefferan; Bradford L Currier; Anthony J Windebank; Michael J Yaszemski
Journal:  Biomacromolecules       Date:  2005 Sep-Oct       Impact factor: 6.988

3.  In-situ hardening hydroxyapatite-based scaffold for bone repair.

Authors:  Yu Zhang; Hockin H K Xu; Shozo Takagi; Laurence C Chow
Journal:  J Mater Sci Mater Med       Date:  2006-05       Impact factor: 3.896

4.  In vivo evaluation of an injectable Macroporous Calcium Phosphate Cement.

Authors:  Sergio del Valle; Natalia Miño; Fernando Muñoz; Antonio González; Josep A Planell; Maria-Pau Ginebra
Journal:  J Mater Sci Mater Med       Date:  2007-02       Impact factor: 3.896

5.  Basic research on aw-AC/PLGA composite scaffolds for bone tissue engineering.

Authors:  Shiho Minamiguchi; Masaaki Takechi; Tetsuya Yuasa; Yukihiro Momota; Seiko Tatehara; Hideyuki Takano; Youji Miyamoto; Kazuhito Satomura; Masaru Nagayama
Journal:  J Mater Sci Mater Med       Date:  2007-08-15       Impact factor: 3.896

6.  High-strength, in situ-setting calcium phosphate composite with protein release.

Authors:  Michael D Weir; Hockin H K Xu
Journal:  J Biomed Mater Res A       Date:  2008-05       Impact factor: 4.396

7.  Premixed macroporous calcium phosphate cement scaffold.

Authors:  Hockin H K Xu; Lisa E Carey; Carl G Simon
Journal:  J Mater Sci Mater Med       Date:  2007-02-03       Impact factor: 3.896

8.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

9.  Compositional and histological comparison of carbonate apatite fabricated by dissolution-precipitation reaction and Bio-Oss®.

Authors:  Kenji Fujisawa; Kazuya Akita; Naoyuki Fukuda; Kumiko Kamada; Takaharu Kudoh; Go Ohe; Takamitsu Mano; Kanji Tsuru; Kunio Ishikawa; Youji Miyamoto
Journal:  J Mater Sci Mater Med       Date:  2018-07-21       Impact factor: 3.896

10.  Novel chelate-setting calcium-phosphate cements fabricated with wet-synthesized hydroxyapatite powder.

Authors:  Toshiisa Konishi; Yukiko Horiguchi; Minori Mizumoto; Michiyo Honda; Kazuya Oribe; Hikaru Morisue; Ken Ishii; Yoshiaki Toyama; Morio Matsumoto; Mamoru Aizawa
Journal:  J Mater Sci Mater Med       Date:  2012-12-11       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.